Dysregulated microRNAs in aflatoxin-induced hepatocellular carcinoma: Serum miR-182 as a potential predictive biomarker

被引:1
|
作者
Livingstone, Merricka C. [1 ]
Johnson, Natalie M. [2 ]
Roebuck, Bill D. [3 ]
Kensler, Thomas W. [4 ]
Groopman, John D. [1 ]
机构
[1] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[2] Texas A&M Sch Publ Hlth, College Stn, TX USA
[3] Dartmouth Med Sch, Hanover, NH USA
[4] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
关键词
D O I
10.1158/1538-7445.AM2018-5401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5401
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Serum miR-182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats
    Livingstone, Merricka C.
    Johnson, Natalie M.
    Roebuck, Bill D.
    Kensler, Thomas W.
    Groopman, John D.
    MOLECULAR CARCINOGENESIS, 2019, 58 (11) : 2017 - 2025
  • [2] Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma
    Abdelrahman, Mohamed M.
    Fawzy, Injie O.
    Bassiouni, Aya A.
    Gomaa, Asmaa I.
    Esmat, Gamal
    Waked, Imam
    Abdelaziz, Ahmed I.
    HUMAN IMMUNOLOGY, 2016, 77 (08) : 667 - 673
  • [3] Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma
    Chen, Lin
    Chu, Feihu
    Cao, Yali
    Shao, Jianguo
    Wang, Feng
    TUMOR BIOLOGY, 2015, 36 (10) : 7439 - 7447
  • [4] A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population
    Moqin Qiu
    Yingchun Liu
    Qiuling Lin
    Zihan Zhou
    Yanji Jiang
    Rongrui Huo
    Xiumei Liang
    Xiangyuan Yu
    Ji Cao
    Xianguo Zhou
    Hongping Yu
    Human Genomics, 14
  • [5] MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma
    Chenggang Wang
    Ren Ren
    Haolin Hu
    Changjun Tan
    Miao Han
    Xiaolin Wang
    Yun Zheng
    ChineseJournalofCancerResearch, 2014, 26 (01) : 17 - 29
  • [6] MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma
    Wang, Chenggang
    Ren, Ren
    Hu, Haolin
    Tan, Changjun
    Han, Miao
    Wang, Xiaolin
    Zheng, Yun
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : 17 - 29
  • [7] Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment
    Liu, Yan
    Wu, Felicia
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2010, 118 (06) : 818 - 824
  • [8] Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373
    Yusuf, Allia Najmie Muhammad
    Ali, Raja Affendi Raja
    Nawawi, Khairul Najmi Muhammad
    Mokhtar, Norfilza Mohd
    MALAYSIAN JOURNAL OF PATHOLOGY, 2020, 42 (03) : 377 - 384
  • [9] Molecular Mechanism of Aflatoxin-Induced Hepatocellular Carcinoma Derived from a Bioinformatics Analysis
    Cai, Peirong
    Zheng, Hao
    She, Jinjin
    Feng, Nannan
    Zou, Hui
    Gu, Jianhong
    Yuan, Yan
    Liu, Xuezhong
    Liu, Zongping
    Bian, Jianchun
    TOXINS, 2020, 12 (03)
  • [10] NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice
    Vartanian, Vladimir
    Minko, Irina G.
    Chawanthayatham, Supawadee
    Egner, Patricia A.
    Lin, Ying-Chih
    Earley, Lauriel F.
    Makar, Rosemary
    Eng, Jennifer R.
    Camp, Matthew T.
    Li, Liang
    Stone, Michael P.
    Lasarev, Michael R.
    Groopman, John D.
    Croy, Robert G.
    Essigmann, John M.
    McCullough, Amanda K.
    Lloyd, R. Stephen
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (16) : 4207 - 4212